Sign in

CIK 0001737953 · Non-accelerated filer<br>Smaller reporting company

Replimune Group, Inc.

Sign in to watch
Ticker
REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
operating
EIN
822082553
Phone
(781) 222-9600
Business address
500 UNICORN PARK, WOBURN, MA, 01801
  1. 424B5 Offering Prospectus
  2. S-3/A Offering Registration Statement
  3. S-3/A Offering Registration Statement
  4. UPLOAD Other SEC-generated Letter
  5. S-3 Offering Registration Statement
  6. S-3 Offering Registration Statement
  7. UPLOAD Other SEC-generated Letter
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. UPLOAD Other SEC-generated Letter
  10. 424B5 Offering Prospectus
  11. 424B5 Offering Prospectus
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. UPLOAD Other SEC-generated Letter
  14. S-3 Offering Registration Statement
  15. 424B5 Offering Prospectus
  16. 424B5 Offering Prospectus
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. UPLOAD Other SEC-generated Letter
  19. S-3 Offering Registration Statement
  20. 424B5 Offering Prospectus

Page 1 of 3 · 48 filings